Clinical trial
Multi-Center, Randomized, Double-Blind, Phase III Trial to Assess the Immunogenicity and Safety of Primary Vaccination With NBP606 in Healthy Infants
NCT02201030 is registered in ClinicalTrials.gov with SK Chemicals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Center, Randomized, Double-Blind, Phase III Trial to Assess the Immunogenicity and Safety of Primary Vaccination With NBP606 in Healthy Infants
- Lead sponsor
- SK Chemicals Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 6, 2014
- Completion date
- October 21, 2016
- Enrollment
- 577 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.